Similar approaches could conceivably extend to attempting to detect cardiac fibrosis. In CFs, protein methylation adds another dimension through PRMT5 (protein arginine methyltransferase), which ...
Together with Bayer, we look forward to bringing this therapeutic option to patients worldwide.” PRMT5 (protein arginine methyltransferase 5) and a specific gene called MTAP (metabolic enzyme 5’-deoxy ...
The companies have collaborated for Suzhou Puhe BioPharma’s oral, small molecule protein arginine N-methyltransferase 5 (PRMT5) inhibitor that selectively targets methylthioadenosine ...
Zacks Investment Research on MSN6d
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharmaBayer BAYRY announced a licensing agreement with Suzhou Puhe BioPharma Co., a clinical-stage biotechnology company.Suzhou ...
1Department of Biology, Yeshiva University, New York, New York. Search for other works by this author on: 1Department of Biology, Yeshiva University, New York, New York. 2Department of Public Health ...
Small Molecule Therapeutic Discovery, Amgen Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback